Articles

Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia

Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
TwinStrand Biosciences, Seattle, WA
Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA
Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA
Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
TwinStrand Biosciences, Seattle, WA
TwinStrand Biosciences, Seattle, WA
TwinStrand Biosciences, Seattle, WA
TwinStrand Biosciences, Seattle, WA
Dept. of Pathology and Laboratory Medicine, Children’s Hospital Los Angeles, Los Angeles, CA
Duke University School of Medicine, Durham, NC
Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA
Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD; Myeloid Malignancies Program, National Institutes of Health, Bethesda, MD
Haematologica Early view Aug 3, 2023 https://doi.org/10.3324/haematol.2023.283520